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ABSTRACT
Background: Uterine fibroids are the most common pelvic tumors. They account for a significant number 
of gynecological consultations. Prevalence, presentation and outcome of treatment vary in different 
communities.
Objectives: To determine the prevalence and clinical presentation of uterine fibroids, and the morbidity 
associated with surgical management of uterine fibroids at Aminu Kano Teaching Hospital, Kano. 
Study design: Retrospective study of all the cases of uterine fibroids that were surgically managed in Aminu 
st st
Kano Teaching Hospital, Kano between 1  January 2006 and 31  December 2010.
Results: The period prevalence of uterine fibroids found in this study was 3.1%, 8.3% of gynecological 
operations were for fibroids. Main presentations were menstrual irregularities 75.9%, abdominal swelling 
51.9%, lower abdominal pain 46.5%, dysmenorrhea 29.1%,  infertility 20.3%. The postoperative 
complication of anemia occurred in 34.1% of patients who had myomectomy and 14.6% of those who had 
hysterectomy. Anemia was 3 times more likely to occur with myomectomy (OR 3.02, CI 1.69-3.56, P 
<0.05). Pyrexia occurred in 31.2% of patients who had myomectomy and 12.4% of those who had 
hysterectomy. It was 3 times more likely to occur following myomectomy than hysterectomy (OR 3.21, CI 
1.74-5.93, P <0.05).Woundinfection occurred in 13.8% and 12.4% of patients who had myomectomy and 
hysterectomy respectively,  UTI  in 6.5% and 5.6% of patients who had myomectomy and hysterectomy . 
They both showed no significant statistical difference between myomectomy and hysterectomy (for wound 
infection OR 1.13, CI 0.56-2.29, P >0.05 and for UTI OR 1.17, CI 0.42-3.23, P >0.05).
Conclusion:The prevalence and presentation of uterine fibroids found in this study is similar to the finding 
of other studies from Northern Nigeria. The most common presentations were menorrhagia and lower 
abdominal swelling, and not infertility. Myomectomy was associated with higher complication rates 
compared to hysterectomy.
Key words: Uterine fibroids, prevalence, presentation, postoperative morbidity.
INTRODUCTION
Uterine fibroid; also called leiomyoma, myoma, 
or fibromyoma; is a benign tumor that originates 
from the myometrium and the accompanying 
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1connective tissues of the uterus . 
Uterine fibroid is the commonest tumor of the 
female genital tract, and the most common 
2benign tumor in women of childbearing age . It 
is estimated that 20% - 45% of women above 
3the age of 30 years have uterine fibroids . They 
4also account for 68.1% of hysterectomies . An 
incidence of 17.9% - 26% has been found at 
5laparoscopy in a Nigerian study . Other studies 
in Nigeria have reported prevalence of 13.6% of 
6all gynecological admissions in the south east , 
9.3% of all gynecological cases in the south 
7west , and 8.8% of gynecological surgeries in 
8the North . An incidence of 11% has been 
9reported from Europe and United States . 
Fibroids are more common in black women 
10than in Caucasian women .Over expression of 
estrogen receptor (ER) alpha genotype and 
aromatase, which has been found to correlate 
with incidence and size of uterine fibroids, is 
particularly pronounced in Afro-American 
women and may explain why African American 
women are 2-5 times more at risk for fibroids 
than white women, and Negros 3-9 times more 
at risk than Caucasians. Aromatase inhibitors 
are currently being considered for prevention 
11and treatment of uterine fibroids . Also, the 
higher incidence among Negros has been 
attributed to myometrial irritation caused by 
pelvic infections, which was found to be 
12prevalent in black women . 
The exact cause of uterine fibroid is unknown 
but there are several risk factors. These include 
Afro-American descent, nulliparity, obesity, 
polycystic ovary syndrome, diabetes and 
13hypertension . A positive family history of 
fibroids was also found to be common in 
patients who develop tumors and the presence 
of a gene encoding for fibroid development has 
been suggested. First degree relatives have a 2-5 
14fold risk of developing fibroids .Fibroid growth 
is strongly dependent on estrogen and 
progesterone, which are regarded as growth 
15promoting . 90% of fibroids cease to grow or 
regress after menopause following estrogen 
withdrawal. Paradoxically, fibroids will rarely 
grow during pregnancy despite very high steroid 
hormone levels. The mechanism(s) by which 
pregnancy exerts its protective effects is unclear, 
but may be mediated by an interaction of 
16estrogen, prostaglandins and oxytocin , 
4although a study from Nigeria  did not agree with 
this. Fibroids have also been associated with 
complications of pregnancy such as spontaneous 
abortions, preterm delivery, abnormal 
presentation, pelvic outlet obstruction, 
postpartum hemorrhage and puerperal and post 
2abortal sepsis . In another study a high incidence 
of uterine fibroid among overweight women 
aged 26 – 30years was noted and weight 
reduction appears to be a possible preventive 
17measure against the disease .
Uterine fibroids have been associated with 
infertility. They may be a consequence of the 
2infertility, or a possible cause of the infertility . 
7 8 Infertility rates of 31.9%  and 41.9% have been 
reported in Nigerian studies, while studies from 
Caucasians and more developed countries give 
18lower rates of between 2.4% and 2.7% . Pelvic 
inflammatory disease has been found to be 
frequently associated with uterine fibroids in this 
environment contributing significantly to the 
12cause of infertility in our patients . Various 
studies have found rates of pelvic inflammatory 
disease associated with fibroids in this 
12environment to range between 28.2% and 68% .
Uterine fibroids are asymptomatic in many 
women and are discovered incidentally in 
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women undergoing evaluation for other reasons 
such as infertility. The highest prevalence has 
6-8been found to be between 30-39years . When 
symptoms occur they are usually menstrual 
abnormalities, which include irregular 
menstrual bleeding and menorrhagia. Other 
features of fibroids occur due to its pressure 
2effect on surrounding tissues and organ . Studies 
in Nigeria found the most common presentation 
to be infertility in 22.9%, abdominal mass in 
21.6%, and menstrual abnormality in 15.9% in 
6the south east , while in the south west it was 
menstrual abnormality in 47.7%, abdominal 
7swelling in 39.1% and infertility in 31.9% . 
Some complications that could arise include 
torsion of pedunculated fibroids, heavy 
bleeding, infertility and degenerative changes. 
Sarcomatuos change is very rare, about 0.1%-
190.5% . Uterine fibroids may be single or 
multiple, and of various sizes. Based on the 
location, they may be submucous, intramural, 
subserous, cervical, or parasitic, and diagnosis is 
2usually made by ultrasound scan .
Treatment may be expectant for asymptomatic 
cases, medical or surgical. Factors that influence 
the management include age, parity, pregnancy 
status, associated symptoms and reproductive 
20potentials of the patient . Hysterectomy is a 
major procedure that involves removal of the 
uterus, and is the definitive treatment for 
2symptomatic fibroid . It has been noted that 
uterine fibroid form the bulk of indication for 
hysterectomy in most countries particularly 
4among  the  p remenopausa l  women .  
Myomectomy involves removal of the fibroids 
alone leaving the rest of the uterus, and is usually 
reserved for women who have fibroids, who are 
under 40 and who desire to maintain their 
fertility, when there is a reasonably good chance 
of subsequent pregnancy and when the 
procedure is surgically feasible. In our 
environment, there is a high association of 
pelvic inflammatory disease and tubal damage 
with uterine fibroids, the presentation is usually 
late with gross damage to the uterus but the 
average Nigerian woman cherishes her 
menstrual function and would not readily 
consent to hysterectomy. Hence myomectomy is 
often performed even when the chance of 
21reproductive function is minimal or absent . 
These factors are probably responsible for the 
varying rates for hysterectomy reported in the 
literature. In Nigeria, the rates for hysterectomy 
for fibroids vary between 10.0% and 45.3%% 
while for myomectomy the rate is between 
6,754.7% and 90.0% .
The effect of abdominal myomectomy on 
reproductive performance has been reviewed in 
many studies. Results not only suggested a 
significant improvement in women presenting 
with infertility but also in those presenting with 
22pregnancy loss . Reproductive outcome after 
surgery is however determined by age, presence 
or absence of tubal abnormality and the duration 
22of infertility before surgery . A study from 
Ibadan showed a pregnancy rate of 37.5% in 
patients who had myomectomy only for 
infertility with the rate dropping to 4.2% in those 
5who had both myomectomy and tubal surgery , 
while another study in UK found similar result 
with pregnancy rate of 35.7% following 
23myomectomy . In one study, the life birth rate 
24after myomectomy was found to be 48% . 
Morbidity associated with surgical management 
of uterine fibroids varies. Some studies report 
increase in  complicat ion rates  with 
2myomectomy , while another study found no 
significant difference in the perioperative 
morbidity between myomectomy and 
hysterectomy, and concluded that myomectomy 
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should be considered a safe alternative to 
25hysterectomy . The study in south west Nigeria 
found the major postoperative complications to 
be pyrexia in 13.5%, anemia in 12.8%, and 
7wound infection in 5.1% .
Newer techniques include the use of laser 
vaporization, ultrasonic diathermy coagulation 
to burn the fibroid nodules, and laparoscopic 
2myomectomy . Gonadotrophin releasing 
hormone analogs and Uterine Artery 
Embolization (UAE) reduce the blood supply to 
the uterus and fibroids, thus making them to 
2shrink . These procedures would be popular in 
developing countries where culture often 
makes women to resent undergoing major 
26surgery or losing their uterus .However, the 
expensive equipments and cost of the 
procedures make them often out of the reach of 
26most developing countries .
It is evident that the determining factors in the 
management of uterine fibroids and the 
outcome of treatment vary widely in different 
communities. It is therefore the purpose of this 
study to analyze the presentation and 
management of uterine fibroids in our 
community, to find out the factors influencing 
management, and also determine the 
postoperative complications of the surgeries.
OBJECTIVES
The objective of this study is to determine the 
prevalence, presentation and morbidity 
associated with surgical management of uterine 
fibroids in Aminu Kano Teaching Hospital, 
Kano.
MATERIALS AND METHODS
It was a retrospective study of the cases of 
uterine fibroids that were managed at the Aminu 
Kano Teaching Hospital, Kano, Nigeria, 
between the 1st January 2006 and 31st 
December 2010. The patients' identification data 
were retrieved from the gynaecological ward 
admission and discharge record books and 
theatre's operation register. Their case notes 
were retrieved from the Medical Records 
Department, and analyzed for incidence, age, 
parity, clinical presentation, type of surgical 
treatment, intra operative findings and 
postoperative complications. During the study 
period, myomectomy was done using the 
tourniquet method, in which a tourniquet was 
applied round the lower uterine segment and 
below the fibroids, to achieve mechanical 
vasoconstriction on the ascending uterine artery 
bilaterally. A tourniquet time was kept and the 
tourniquet was released after 30 minutes and 
reapplied after 5 minutes to re-establish blood 
flow and prevent irreversible damage to the 
uterine muscle cells. 
Post operatively, a packed cell volume of less 
than 30% was considered as anaemia, a 
otemperature of 38 C or more on two consecutive 
days after the first postoperative day, was 
considered as pyrexia, dysuria and/or frequency 
of micturition with positive urine microbiology 
culture, was taken as urinary tract infection 
(UTI), and local erythema or suppuration was 
considered as wound infection. 
The data obtained were recorded using tables. 
Statistical analysis was done with chi-square test 
using a commercial statistical package 
(SPSS/PC version 11.0, SPSS Inc., Chicago IL. 
USA.). The Odds Ratio (OR) and 95% 
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confidence interval (CI) were determined where 
appropriate. A P-value of less than 0.05 was 
considered significant.
RESULTS
During the period of study, there were 12,480 
new patients at the gynecological clinic and 
uterine fibroid was diagnosed in 386 giving a 
period prevalence of 3.1%. Surgical operations 
for uterine fibroids were carried out on 319 
patients out of 3821 gynecological operations, 
giving a period prevalence of 8.3% of 
gynecological operations. 316 folders were 
retrieved and analysed giving a retrieval rate of 
99.1%. The Sociodemographic characteristics 
of the patients are shown in Table 1. The highest 
incidence (48.1%) was in the 30-39 years age 
group, and the lowest (4.4%) was in those 50 
years and above. The age range was 21-54 years 
and the mean age was 36.6 years ± 7.6 years. 
Twenty four (7.6%) were nulliparous, while 73 
(23.1%) were grand multiparous. The mean 
parity was 3 ± 1.5.Table 2 shows the presenting 
complaints of the patients. Menstrual 
abnormality, mainly menorrhagia, was the 
commonest symptom, occurring in 75.9% of the 
patients. 51.9% presented with abdominal 
swelling. Lower abdominal pain and 
dysmenorrhea were present in 146 (46.5%) and 
92 (29.1%) patients respectively. 64 (20.3%) 
patients presented with infertility, of which 
37.5% was primary and 62.5% secondary. 63 
(19.9%) patients had anemia, 52 (16.5%) had 
spontaneous abortion, and 2 (0.63%) had a 
vaginal mass at presentation (fibroid polyp).
The types of surgical procedure performed on 
the patients are shown in Table 3. Abdominal 
myomectomy was performed in 138 (43.7%) 
patients. 178 (56.3%) patients had abdominal 
hysterectomy while none had vaginal 
hysterectomy. Two of the patients initially 
planned for myomectomy eventually had total 
abdominal hysterectomy performed on them 
because of technical difficulty at surgery.Most 
of the nulliparous patients had abdominal 
myomectomy (83.3%), whereas hysterectomy 
was preferred in grandmultiparous patients and 
most of them (97.3%) had hysterectomy instead 
of myomectomy. Three out of 58 patients who 
had myomectomy for infertility conceived 
afterwards, giving a pregnancy rate of 5.2% 
within one-year follow-up. Table 4 shows the 
postoperative complications. Postoperative 
anemia (23.1%) was the most common 
complication, followed by pyrexia (20.6%), 
wound infection (13.0%), and UTI (6.0%).  
Postoperative anemia (OR = 3.02, CI = 1.69-
3.56, P < 0.05), and pyrexia (OR = 3.21, CI = 
1.74-5.93, P < 0.05) showed statistically 
significant association with myomectomy. 
Postoperative anemia and pyrexia occurred 3 
times more among patients who had 
myomectomy compared to hysterectomy. There 
was no statistically significant difference 
(P>0.05) in the frequency of urinary tract 
infection and wound infection. There was no 
mortality.
118
Trop J Obstet Gynaecol, 30 (2), August 2013
Table 2: Clinical Presentation Of Patients
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+ Anemia: PCV of <30%
++ Pyrexia: Temperature of 38 0C or more on at least 2 consecutive days excluding the first 24 
hours post operatively.
+++ UTI: dysuria and/or increased frequency with positive urine microbiology culture.
++++ Wound infection: local wound erythema or suppuration.
DISCUSSION
The period prevalence of uterine fibroids found 
in this study was 3.1%. Surgery for uterine 
fibroid accounted for 8.3% of all gynecological 
operations.  This is similar to the finding in 
8
Gombe in northern Nigeria (8.8%) .
Uterine fibroids occurred most often in the age 
groups 30 and 39 years (48.1%). This figure is 
6-8, 27
comparable with findings from other centres , 
which may be because uterine fibroids are 
uncommon before the age of 30 years and after 
9
menopause . 
Seven point six percent (7.6%) of the patients 
w e r e  n u l l i p a r o u s ,  a n d  2 3 . 1 %  w e r e  
grandmultiparous. The Study from Gombe in 
north Eastern Nigeria, where early girl marriage 
nulliparous. These patients presented with both 
symptoms of infertility and disturbing 
menorrhagia, were also perimenopausal and 
were found to have giant uterine fibroids making 
myomectomy either unsuitable or technically 
difficult.
Postoperative anaemia and pyrexia were the 
commonest postoperative morbidity, which 
2, 7agrees with other studies . Postoperative 
anaemia and pyrexia occurred more with 
myomectomy than hysterectomy, which may 
probably be due to bleeding into the fibroid 
cavities and peritoneum, with resultant 
2reactionary pyrexia following myomectomy , so 
effort must be made to obliterate all dead spaces 
2at surgery . The higher frequency of 
complications with myomectomy compared to 
hysterectomy in this study, agree with other 
2, 7studies , though another study found no 
significant difference between the complication 
rates for myomectomy and hysterectomy, and 
concluded that myomectomy is a safe 
25alternative to hysterectomy . Reduction of 
morbidity associated with myomectomy can be 
achieved by using endoscopic methods like da 
Vinci Myomectomy, which is a new category of 
minimally invasive myomectomy, and the latest 
evolution in robotics technology, which 
combines the best of open and laparoscopic 
2 8su rge ry .  Wi th  min imal ly  invas ive  
myomectomy using endoscopic methods, 
surgeons can remove uterine fibroids through 
small incisions with unmatched precision and 
control, and carry out comprehensive 
reconstruction of the uterine wall, regardless of 
the size or location of the fibroids. Among the 
potential benefits of minimally invasive 
myomectomy using endoscopic methods as 
compared to traditional open abdominal surgery 
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is also common, similarly recorded a low 
8frequency of nulliparity among their patients . 
Studies from the southern parts of Nigeria 
recorded high frequency of nulliparity among 
6, 7the patients , and this may be because 
prolonged periods of voluntary infertility from 
delayed age of marriage, are usually associated 
with development of uterine fibroids and 
2primary infertility .The major presenting 
symptoms were menorrhagia, abdominal 
swelling, lower abdominal pain and infertility. 
6-This agrees with the findings from other studies
8, 27.
The most common surgical management for 
uterine fibroids was hysterectomy, done for 
56.3% of the patients, while 43.7% had 
myomectomy. None had vaginal hysterectomy, 
or other forms of surgical treatment. The two 
patients that presented with vaginal masses had 
additional multiple uterine nodules and had 
hysterectomy done. The high association of 
uterine fibroids with pelvic inflammatory 
disease and pelvic adhesions, and the large size 
26of most fibroids in developing countries , has 
been found to be the reason why vaginal 
hysterectomy is not commonly employed in the 
management of uterine fibroids, because of the 
26technical difficulties that may be involved . 
This may explain why vaginal hysterectomy 
was not employed in the management of uterine 
fibroids in this study. This is different from the 
f indings  in  southern Niger ia  where  
myomectomy was the major surgical method of 
treatment, due to the high frequency of 
6, 7nulliparity among their patients .Most of the 
patients who had low parity had myomectomy 
where as those with high parity mostly had 
hysterectomy. Three patients in this study had 
hysterectomy even though they were 
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are: better opportunity for future pregnancy, 
significantly less pain, less blood loss, fewer 
complications with less scarring and possibility 
of uterine rupture during future pregnancies, a 
shorter hospital stay, and a faster return to 
28normal daily activities . 
Wound infection and urinary tract infection 
which did not show statistically significant 
difference between myomectomy and 
hysterectomy cases, may be a result of poor 
environmental and personal hygiene in our 
community in a developing country, and 
urethral catheterization, which has been known 
to predispose to postoperative patients to 
26urinary tract infection . The uterine tourniquet 
which was applied round the lower uterine 
segment and below the fibroids during 
myomectomy in this study is a mechanical 
vaso-occlusive technique to achieve 
mechanical vasoconstriction on the ascending 
uterine artery bilaterally. It has been found to be 
associated with low risk of haemorrhage and 
difficulty with securing haemostasis, as well as 
post-operative morbidity, shorter mean 
29duration of operation and hospital stay . 
There was no mortality, probably because of 
meticulous care and the surgeries were done 
with consultant gynecologist's participation.
CONCLUSION
Surgical operations for uterine fibroids are 
common gynaecological operations in Aminu 
Kano Teaching Hospital. Menorrhagia and 
abdominal swelling were most common 
presentations. Myomectomy and hysterectomy 
were the only two modalities for surgical 
management of uterine fibroids used during the 
study period. Myomectomy was associated 
with higher postoperative morbidity than 
hysterectomy.
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